These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15713541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
    Simon S, Mueller SO.
    Toxicology; 2006 Mar 15; 220(2-3):90-103. PubMed ID: 16413649
    [Abstract] [Full Text] [Related]

  • 5. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
    van der Burg B, Winter R, Man HY, Vangenechten C, Berckmans P, Weimer M, Witters H, van der Linden S.
    Reprod Toxicol; 2010 Aug 15; 30(1):18-24. PubMed ID: 20438827
    [Abstract] [Full Text] [Related]

  • 6. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
    Freyberger A, Witters H, Weimer M, Lofink W, Berckmans P, Ahr HJ.
    Reprod Toxicol; 2010 Aug 15; 30(1):9-17. PubMed ID: 19836445
    [Abstract] [Full Text] [Related]

  • 7. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
    Tamura H, Ishimoto Y, Fujikawa T, Aoyama H, Yoshikawa H, Akamatsu M.
    Bioorg Med Chem; 2006 Nov 01; 14(21):7160-74. PubMed ID: 16876421
    [Abstract] [Full Text] [Related]

  • 8. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
    Sonneveld E, Riteco JA, Jansen HJ, Pieterse B, Brouwer A, Schoonen WG, van der Burg B.
    Toxicol Sci; 2006 Jan 01; 89(1):173-87. PubMed ID: 16221957
    [Abstract] [Full Text] [Related]

  • 9. Effect of bisphenol A, tetrachlorobisphenol A and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene.
    Sun H, Xu LC, Chen JF, Song L, Wang XR.
    Food Chem Toxicol; 2006 Nov 01; 44(11):1916-21. PubMed ID: 16893599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improved androgen specificity of AR-EcoScreen by CRISPR based glucocorticoid receptor knockout.
    Zwart N, Andringa D, de Leeuw WJ, Kojima H, Iida M, Houtman CJ, de Boer J, Kool J, Lamoree MH, Hamers T.
    Toxicol In Vitro; 2017 Dec 01; 45(Pt 1):1-9. PubMed ID: 28803809
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS, Marks BD, Gowda K, Kupcho KR, Ervin KM, De Rosier T, Qadir N, Eliason HC, Riddle SM, Shekhani MS.
    Biochemistry; 2007 Jan 23; 46(3):683-95. PubMed ID: 17223690
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro.
    Xu LC, Liu L, Ren XM, Zhang MR, Cong N, Xu AQ, Shao JH.
    Toxicology; 2008 Jan 14; 243(1-2):59-65. PubMed ID: 17980950
    [Abstract] [Full Text] [Related]

  • 16. Development and pre-validation of an in vitro transactivation assay for detection of (anti)androgenic potential compounds using 22Rv1/MMTV cells.
    Sun S, Park EJ, Choi YH, Lee HS, Ahn BY, Dong MS.
    Reprod Toxicol; 2016 Apr 14; 60():156-66. PubMed ID: 26867867
    [Abstract] [Full Text] [Related]

  • 17. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
    Hartig PC, Bobseine KL, Britt BH, Cardon MC, Lambright CR, Wilson VS, Gray LE.
    Toxicol Sci; 2002 Mar 14; 66(1):82-90. PubMed ID: 11861975
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.